| Title |
Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
|
|---|---|
| Published in |
Cancer Cell, March 2013
|
| DOI | 10.1016/j.ccr.2013.02.017 |
| Pubmed ID | |
| Authors | |
| Abstract |
We performed a loss-of-function RNA interference screen to define therapeutic targets in multiple myeloma, a genetically diverse plasma cell malignancy. Unexpectedly, we discovered that all myeloma lines require caspase-10 for survival irrespective of their genetic abnormalities. The transcription factor IRF4 induces both caspase-10 and its associated protein cFLIPL in myeloma, generating a protease that does not induce apoptosis but rather blocks an autophagy-dependent cell death pathway. Caspase-10 inhibits autophagy by cleaving the BCL2-interacting protein BCLAF1, itself a strong inducer of autophagy that acts by displacing beclin-1 from BCL2. While myeloma cells require a basal level of autophagy for survival, caspase-10 tempers this response to avoid cell death. Drugs that disrupt this vital balance may have therapeutic potential in myeloma. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 60% |
| Turkey | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Scientists | 1 | 20% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Norway | 1 | <1% |
| Japan | 1 | <1% |
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 194 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 48 | 24% |
| Researcher | 37 | 19% |
| Student > Master | 25 | 13% |
| Student > Bachelor | 16 | 8% |
| Other | 11 | 6% |
| Other | 28 | 14% |
| Unknown | 35 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 70 | 35% |
| Biochemistry, Genetics and Molecular Biology | 44 | 22% |
| Medicine and Dentistry | 24 | 12% |
| Immunology and Microbiology | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 7 | 4% |
| Unknown | 41 | 21% |